Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
Activity
RulesProposed and final rules open for commentGrantsFederal funding opportunities and deadlinesPress releasesWhat agencies are announcing publiclyHearingsCongressional committee hearings and meetingsBillsLegislation, actions, amendments, and votes
Views
AgenciesEverything from a single federal agencyTopicsActivity grouped by policy areaOrganizationsCompanies, associations, and advocacy groupsCommitteesHouse, Senate, and joint committee activityLegislatorsMembers of Congress, service, bills, and votes
Pricing
LoginCreate account

Table of contents

DetailsRelated

Attachment II - RS OB Page

FDA-2026-P-7181-0004Supporting & Related Material
Document

Details

The document's own metadata, straight from the source system.

Title
Attachment II - RS OB Page
Posted
Jun 29, 2026
Agency
Food and Drug Administration (FDA)
Topics
  • Pharmaceutical Policy
View on regulations.gov ↗
Related

Related documents

Other documents filed with this rulemaking.

View related documents
Other
Completeness Assessment Correspondence to Senores Pharmaceuticals, Inc.
No comment periodJul 28, 2026
Other
Amendment to Suitability Petition from Senores Pharmaceuticals, Inc.
No comment periodJul 21, 2026
Supporting & Related Material
Attachment IV - RL-Tablet-OB Page
No comment periodJun 29, 2026
Supporting & Related Material
Attachment I - RDL OB Page
No comment periodJun 29, 2026
Other
Acknowledgement Letter from FDA DMB to Senores Pharmaceuticals, Inc.
No comment periodJun 29, 2026
Supporting & Related Material
Attachment V - draft-package insert
No comment periodJun 29, 2026
Other
Suitability Petition from Senores Pharmaceuticals, Inc.
No comment periodJun 29, 2026
Supporting & Related Material
Attachment III - RL-package insert
No comment periodJun 29, 2026

On this page

DetailsRelated
Government ContextGovernment Context

Track federal rulemaking documents, topics, and agencies — built on primary sources across the federal government.

ActivityRulesGrantsPress releases
ViewsAgenciesTopicsOrganizations
GuidesInstall Government ContextFive questions to ask your agentAll guides
CompanyAboutData sourcesPricing
LegalPrivacyTerms
© 2026 Government Context. Built on primary government sources.Not affiliated with any U.S. government agency.